Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
10/2005
10/13/2005US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications
10/13/2005US20050227233 Method for diagnosing and treating schizophrenia
10/13/2005US20050226866 Bone morphogenic protein specific immunoglobulin for treatment of bone diseases; immunotherapy
10/13/2005DE202005005194U1 Formicarium comprises tank with two false bottoms which cover quarter to third of its surface and are mounted on rails, allowing them to be withdrawn
10/13/2005CA2563015A1 Transgenic fish with increased unsaturated fatty acid content
10/13/2005CA2561702A1 Methods for altering protein production rates
10/13/2005CA2561534A1 Ion channel
10/13/2005CA2560011A1 Cospeptin, cosmedin and their uses
10/12/2005EP1583837A1 Targeted transgenesis using the rosa26 locus
10/12/2005EP1583829A1 Methods of treatment of feeding disorders or disorders of glucose uptake and for modifying metabolism and identifying therapeutic reagents therefor
10/12/2005CN2731975Y Automatic sterilizing device with double controller for silkworm rearing chamber
10/12/2005CN1681921A Sperm cell processing and preservation systems
10/12/2005CN1680600A Polymorphic point of stearyl cozymase A desaturase gene mononucleotide for identifying behavior for back fat thickness of pig and use thereof
10/12/2005CN1680599A Polymorphic point of a1, 2-fucose transferase gene mononucleotide for identifying resistances of hydrops and diarrhea of weaned piglets and use thereof
10/11/2005US6953875 Animal model for use in the treatment and diagnosis of cancers
10/11/2005US6953874 Transgenic animals having a modified glycoprotein V gene
10/11/2005US6953681 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/06/2005WO2005093051A1 INACTIVE Ca2+/CALMODULIN-DEPENDENT PROTEIN KINASE IIα KNOCKIN ANIMAL AND KNOCKIN CELL OF THE SAME
10/06/2005WO2005092090A1 Obesity model animal and drug evaluation method using the same
10/06/2005WO2005072066A3 Preventive or therapeutic agent for diabetic maculopathy
10/06/2005WO2005054445A8 A method for isolating a self-renewing, multipotent slow-cycling cell
10/06/2005WO2005007877A3 Regulatable promoters for synthesis of small hairpin rna
10/06/2005WO2004094603A3 Transgenic mouse with simplified dh locus
10/06/2005WO2004080406A3 Therapeutic compositions
10/06/2005WO2004041193A3 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5
10/06/2005WO2004032877A3 Compositions, organisms and methodologies employing a novel human kinase
10/06/2005US20050223420 Inducible heart attack animal model
10/06/2005US20050223418 Porcine CMP-N-Acetylneuraminic acid hydroxylase gene
10/06/2005US20050223417 Germ line and somatic cells comprising a mutant p27kip1 protein lacking a Cdk2 phosphorylation site; side effect reduction
10/06/2005US20050223416 C1 inhibitor produced in the milk of transgenic mammals
10/06/2005US20050222391 Method of constructing antibody
10/06/2005US20050221466 Alanine 2,3,aminomutase
10/06/2005US20050221371 Diagnosis of diseases related to an alteration in the regulation or in the coding regions of the RBP-7 gene and for prognosis/diagnosis of an eventual treatment with agents acting on pathologies involving abnormal cell proliferation and/or abnormal cell differentiation.
10/06/2005US20050221346 May be used to detect the presence of a cancer or to evaluate the prognosis of a known disease
10/06/2005US20050221344 Interferon-Like molecules and uses thereof
10/06/2005US20050221322 Multiple closed nucleus breeding for swine production
10/06/2005US20050221303 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/06/2005US20050221287 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
10/06/2005DE102004045284B3 Vorrichtung, Verwendung der Vorrichtung und Verfahren zur Aufzucht von Calliphoriden-Larven Apparatus, using the apparatus and method for rearing larvae Calliphoriden
10/06/2005CA2568935A1 Inactive ca2+/calmodulin-dependent protein kinase ii.alpha. knockin animal and knockin cell of the same
10/05/2005EP1581624A2 Eukaryotic genes involved in adult lifespan regulation
10/05/2005EP1071471A4 Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene
10/05/2005CN1678623A A robust, inducible cardiac preferred expression system for transgenesis
10/05/2005CN1678189A Methods for developing animal models
10/05/2005CN1675993A Nanjing fairy shrimp egg proliferating method
10/05/2005CN1221569C Cell surface molecule mediating cell adhesion and signal transmission
10/05/2005CN1221165C Automatic heating and humidifying device for breeding silkworm
09/2005
09/30/2005CA2460437A1 Crh and pomc effects on animal growth
09/29/2005WO2005090996A1 Sirt6 transgenic non-human animals and assay methods
09/29/2005WO2005090580A1 Using nonhuman animal model, method of measuring transcription activity, method of measuring cell quantity and method of measuring tumor volume
09/29/2005WO2005090561A1 Method of screening activation inhibitor for macrophage cell
09/29/2005WO2005089539A1 Transgenic model for alzheimer’s disease
09/29/2005WO2005089411A2 Tissue products from animals lacking functional alpha 1,3 galactosyl transferase
09/29/2005WO2004113552A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
09/29/2005US20050216966 Method of constructing germline chimeric animal
09/29/2005US20050216964 Using swine organs devoid of porcine endogenous retrovirus (PERV) for xenotransplantation and treatment of end-stage organ diseases
09/29/2005US20050216963 Prion-free transgenic ungulates
09/29/2005US20050216962 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
09/29/2005US20050216961 Cancer associated protein kinases and their uses
09/29/2005US20050216960 Using tumor necrosis factor related apoptosis inducing ligand receptor (TRAIL-R) to identify modulators of dendritic cell immune response
09/29/2005US20050216959 Using biobolistic electric discharge particle acceleration to transfer gold coated beads into cells; improving heterologous gene transfer and expression
09/29/2005US20050214944 Using single-stranded nucleic acids and homologus recombination to correct defects in tumor suppressor genes; treating and preventing cell proliferative disorders; gene therapy
09/29/2005US20050214910 Chordin-like molecules and uses thereof
09/29/2005US20050214867 Prion protein standard and method of making same
09/29/2005US20050214856 Nucleotide sequences coding bone morphogenic protein for identifying modulators for treatment of bone diseases
09/29/2005US20050214837 Antibody specific for mutant presenilin 1 and method of use thereof
09/29/2005US20050214794 Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for alstroem syndrome
09/29/2005US20050214780 Using polymorphism in potassium channel interacting protein (KChIP1) as diagnostic indicator for pancreatic disorders
09/29/2005US20050214293 Containing heavy and light chain complementarity determining region 1,2 and 3 components of amino acid sequences 1-6; reduced immunogenicity; increased affinity and avidity; improved cell culturing
09/29/2005US20050214275 Noninvasive fat modulation; utilizing active agents having reactive selectivity to metabolic regulatory system of cells; drug screening; animal models
09/29/2005US20050214252 Chordin-like molecules and uses thereof
09/29/2005US20050214220 Tumor model
09/29/2005US20050214211 Active and/or passive immunization; accurate early stage, localized tumor detection
09/29/2005CA2560551A1 Transgenic model for alzheimer's disease
09/29/2005CA2559936A1 Methods and compositions for using alveolar macrophage phospholipase a2
09/29/2005CA2559720A1 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
09/28/2005EP1580264A1 Construction of knockdown animal by transferring double-stranded rna expression vector
09/28/2005EP1578987A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
09/28/2005EP1578981A2 Tumor endothelial marker 7alpha molecules and uses thereof
09/28/2005EP1578967A1 Fluorescent proteins from aquatic species
09/28/2005EP1578906A2 Afap sequences, polypeptides, antibodies and methods
09/28/2005EP1578767A2 Methods and materials for modulating trpm2
09/28/2005EP1578252A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
09/28/2005EP1578192A2 Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer
09/28/2005EP1439849A4 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
09/28/2005EP1436393A4 Rapid method of selecting cells for gene disruption by homologous recombination
09/28/2005EP1423695A4 Androgen receptor knock-out transgenic animals
09/28/2005EP1250060B1 Rearing of aquatic species with dha-rich prey organisms
09/28/2005EP1137766B1 Use of il-12 antibodies to treat psoriasis
09/28/2005CN1675359A Novel forms of interfering rna molecules
09/28/2005CN1674779A Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained
09/28/2005CN1673361A Multipotential cell containing heterogenous nuclear and mitochondrion
09/28/2005CN1672506A Method of producing white calf beef with male calf
09/28/2005CN1220430C Gravity-free condition simulating method and apparatus of treating fertilized egg of aquatic animal
09/28/2005CN1220429C Method for layered raising broiler and pig in same shed in the northern cold area
09/27/2005US6949692 Detection of genetic position of preferential mutation in rodents; obtain rodent, mate, monitor offspring for preferential phenotypes, mate offspring, monitor expression of mutant phenotypes
09/27/2005US6949691 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies
09/27/2005US6949690 Methods of assessing the effect of a gene of interest on human prostate cancer progression
09/27/2005US6949361 Polynucleotide
09/27/2005CA2250682C Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes